Laboratoire de Bioimagerie et Pathologies


Logo Universite de strasbourg


Sur ce site

Sur le Web du CNRS

Accueil du site > Equipe Signalisation tumorale et cibles thérapeutiques > Publications

Publication 2015

22 janvier 2016

A. ABUSNINA, T. KERAVIS, Q. ZHOU, H. JUSTINIANO, A. LOBSTEIN & C. LUGNIER. Tumour growth inhibition and anti-angiogenic effects using curcumin correspond to combined PDE2 and PDE4 inhibition. Thromb. Haemost. 113, 319-328, 2015 – IF 4.98 – EQ2

H. ANTON, N. TAHA, E. BOUTANT, L. RICHERT, H. KHATTER, B. KLAHOLZ, P. RONDE, E. REAL, H. de ROCQUIGNY & Y. MELY. Investigating the cellular distribution and interactions of HIV-1 Nucleocapsid protein by quantitative fluorescence microscopy. PLoS One 10, e0116921, 2015 – IF 3.23 – EQ1-EQ2

E. AYME-DIETRICH, H. MARZAK, R. LAWSON, W. MOKNI, O. WENDLING, R. COMBE, J. BECKER, L.E. FERTAK, M.F. CHAMPY, R. MATZ, R. ANDRIANTSITOHAINA, S. DOLY, K. BOUTOURLINSKY, L. MAROTEAUX & L. MONASSIER. Contribution of serotonin to cardiac remodeling associated with hypertensive diastolic ventricular dysfunction in rats. J. Hypertens. 33, 2310-2321, 2015 IF 4.72 – EQ2-EQ3

A.F. BLANDIN, G. RENNER, M. LEHMANN, I. LELONG-REBEL, S. MARTIN & M. DONTENWILL. β1 integrins as therapeutic targets to disrupt hallmarks of cancer. Front. Pharmacol. 6, 279, 2015 – IF 3.80 – EQ2

A. BOUKHARI, M. ALHOSIN, C. BRONNER, K. SAGINI, C. TRUCHOT, E. SICK, V.B. SCHINI-KERTH, P. ANDRÉ, Y. MÉLY, M. MOUSLI & J.P. GIES. CD47 activation-induced UHRF1 over-expression is associated with silencing of tumor suppressor gene p16INK4A in glioblastoma cells. Anticancer Res. 35, 149-157, 2015 – IF 1.83 – EQ1-EQ2-EQ3

G. CARRE, L. GARNIER, J. MOELLER-SIEGERT, J.P. GIES, V. KELLER, P. ANDRE & N. KELLER. Antibacterial textiles functionalized by layer-by-layer assembly of polyelectrolytes and TiO2 photocatalyst. RSC Adv. 5, 38859-38867, 2015 IF 3.84 – EQ2

F. CLAUSS, A. CHARLOUX, F. PIQUARD, S. DOUTRELEAU, S. TALHA, J. ZOLL, C. LUGNIER & B. GENY. Angiotensin-converting enzyme inhibition prevents myocardial infarction-induced increase in renal cortical cGMP and cAMP phosphodiesterase activities. Fundam. Clin. Pharmacol. 29, 352-361, 2015 IF 2.12 – EQ2

S.E. EL MESHRI, D. DUJARDIN, J. GODET, L. RICHERT, C. BOUDIER, J.L. DARLIX, P. DIDIER, Y. MELY & H. de ROCQUIGNY. Role of the nucleocapsid domain in HIV-1 Gag oligomerization and trafficking to the plasma membrane : A fluorescence lifetime imaging microscopy investigation. J. Mol. Biol. 427, 1480-1494, 2015 – IF 4.33 – EQ1-EQ2

A. JEANNE, E. SICK, J. DEVY, N. FLOQUET, N. BELLOY, L. THERET, C. BOULAGNON-ROMBI, M.D. DIEBOLD, M. DAUCHEZ, L. MARTINY, C. SCHNEIDER & S. DEDIEU. Identification of TAX2 peptide as a new unpredicted anti-cancer agent. Oncotarget 6, 17981-18000, 2015 IF 6.36 – EQ2

A.C. JUNG, A.M. RAY, L. RAMOLU, C. MACABRE, F. SIMON, F. NOULET, A.F. BLANDIN, G. RENNER, M. LEHMANN, L. CHOULIER, H. KESSLER, J. ABECASSIS, M. DONTENWILL & S. MARTIN. Caveolin-1-negative head and neck squamous cell carcinoma primary tumors display increased epithelial to mesenchymal transition and prometastatic properties. Oncotarget 6, 41884-41901, 2015 IF 6.36 – EQ2

T. KERAVIS, L. FAVOT, A.A. ABUSNINA, A. ANTON, H. JUSTINIANO, R. SOLETI, E. ALABED ALIBRAHIM, G. SIMARD, R. ANDRIANTSITOHAINA & C. LUGNIER. Delphinidin inhibits tumor growth by acting on VEGF signalling in endothelial cells. PLoS One 10, e0145291, 2015 IF 3.23 – EQ2

A.J. LEÓN-GONZÁLEZ*, T. SHARIF*, A. KAYALI, M. ABBAS, I. DANDACHE, N. ETIENNE-SELLOUM, C. KEVERS, J. PINCEMAIL, C. AUGER, P. CHABERT, M. ALHOSIN & V.B. SCHINI-KERTH. Delphinidin-3-O-glucoside and delphinidin-3-O-rutinoside mediate the redox-sensitive caspase 3-related pro-apoptotic effect of blackcurrant juice on leukaemia Jurkat cells (*co-premiers auteurs). J. Funct. Food. 17, 847-856, 2015 IF 3.57 – EQ2-EQ3

M. MLIH, L. HOST, S. MARTIN, N. NIEDERHOFFER, L. MONASSIER, J. TERRAND, N. MESSADDEQ, M. RADKE, M. GOTTHARDT, V. BRUBAN, F. KOBER, M. BERNARD, E. CANET-SOULAS, F. ABT-JIJON, P. BOUCHER & R.L. MATZ. The Src Homology and Collagen A (ShcA) adaptor protein is required for the spatial organization of the costamere/Z-disk network during heart development. J. Biol. Chem. 290, 2419-2430, 2015 – IF 4.57 – EQ2-EQ3

Y. NOMINÉ, L. CHOULIER, G. TRAVÉ, T. VERNET & D. ALTSCHUH. Antibody binding selectivity : alternative sets of antigen residues entail high-affinity recognition. PLoS One 10, e0143374, 2015 – IF 3.23 – EQ2

M. SHOLOKH, O.M. ZAMOTAIEV, R. DAS, V.Y. POSTUPALENKO, L. RICHERT, D. DUJARDIN, O.A. ZAPOROZHETS, V.G. PIVOVARENKO, A.S. KLYMCHENKO & Y. MÉLY. Fluorescent amino acid undergoing excited state intramolecular proton transfer for site-specific probing and imaging of peptide interactions. J. Phys. Chem. B 119, 2585-2595, 2015 – IF 3.30 – EQ1-EQ2

T. VERNET, L. CHOULIER, Y. NOMINÉ, L. BELLARD, M. BALTZINGER, G. TRAVÉ & D. ALTSCHUH. Spot peptide arrays and SPR measurements : throughput and quantification in antibody selectivity studies. J. Mol. Recogn. 28, 635-644, 2015 – IF 2.15 – EQ2